Jushi Holdings (JUSHF) Operating Leases (2021 - 2022)

Jushi Holdings (JUSHF) posted quarterly Operating Leases of $18.3 million for Q3 2022, down 7.45% quarter-over-quarter from $19.8 million in Q2 2022.

Jushi Holdings (JUSHF) Operating Leases (2021 - 2022) Analysis & Trends

Jushi Holdings (JUSHF) has reported Operating Leases for 2 consecutive years, with $18.3 million the latest figure, recorded in Q3 2022.

In Q3 2022, Operating Leases changed N/A year-over-year to $18.3 million; the TTM figure through Sep 2022 stood at $18.3 million (changed N/A YoY), while the FY2021 annual figure was $15.2 million, changed N/A from the prior year.
Operating Leases retreated to $18.3 million in Q3 2022 per JUSHF's latest filing, from $19.8 million in the prior quarter.
Across five years, Operating Leases topped out at $19.8 million in Q2 2022 and bottomed at $15.2 million in Q4 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.91 Bn	42.95 Bn	-
2	Teva Pharmaceutical Industries	42.98 Bn	39.32 Bn	2.15 Bn
3	Zoetis	31.53 Bn	29.86 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.61 Bn	22.81 Bn	5.10 Bn
5	United Therapeutics	22.16 Bn	19.49 Bn	683.80 Mn
6	Viatris	18.74 Bn	17.85 Bn	1.46 Bn
7	Neurocrine Biosciences	15.51 Bn	15.12 Bn	935.80 Mn
8	Elanco Animal Health	11.76 Bn	11.23 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.12 Bn	9.95 Bn	-
10	Jushi Holdings	83.87 Mn	50.54 Mn	31.53 Mn

Download Data